Liquidia Corp ($LQDA)

Stock Image

LQDA Overview

Liquidia Corporation, through its subsidiaries, operates as a late-stage clinical biopharmaceutical company.The company focuses on the development and commercialization of various products using its PRINT technology that enables precise production of drug particles designed to enhance the safety, efficacy, and performance of a range of therapies.Its product candidates include LIQ861 for the treatment of pulmonary arterial hypertension; and LIQ865 for the treatment of local post-operative pain.The company also provides strategy, investment, and commercialization services for rare disease pharmaceutical products, such as generic Remodulin, a parenteral formulation of treprostinil for pulmonary arterial hypertension.Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina. (From: StockAnalysis.com)

MORE ABOUT Liquidia Corp

Stay up to date with the best of Bullish each week.


Stay up to date with the best of Bullish each week.